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The analysis of HIV-1 sequences has helped understand the viral molecular epidemiology, monitor the development of antiretroviral drug resistance, and design candidate vaccines. The introduction of single genome
amplification (SGA) has been a major advancement in the field, allowing for the characterization of multiple
sequences per patient while preserving linkage among polymorphisms in the same viral genome copy.
Sequencing of SGA amplicons is performed by capillary Sanger sequencing, which presents low throughput,
requires a high amount of template, and is highly sensitive to template/primer mismatching. In order to meet the
increasing demand for HIV-1 SGA amplicon sequencing, we have developed a platform based on benchtop nextgeneration sequencing (NGS) (IonTorrent) accompanied by a bioinformatics pipeline capable of running on
computer resources commonly available at research laboratories. During assay validation, the NGS-based sequencing of 10 HIV-1 env SGA amplicons was fully concordant with Sanger sequencing. The field test was
conducted on plasma samples from 10 US Navy and Marine service members with recent HIV-1 infection
(sampling interval: 2005–2010; plasma viral load: 5,884–194,984 copies/ml). The NGS analysis of 101 SGA
amplicons (median: 10 amplicons/individual) showed within-individual viral sequence profiles expected in
individuals at this disease stage, including individuals with highly homogeneous quasispecies, individuals with
two highly homogeneous viral lineages, and individuals with heterogeneous viral populations. In a scalability
assessment using the Ion Chef automated system, 41/43 tested env SGA amplicons (95%) multiplexed on a single
Ion 318 chip showed consistent gene-wide coverage > 50×. With lower sample requirements and higher
throughput, this approach is suitable to support the increasing demand for high-quality and cost-effective HIV-1
sequences in fields such as molecular epidemiology, and development of preventive and therapeutic strategies.

Keywords:
Next-generation sequencing
HIV-1
Single genome amplification
Bioinformatics
IonTorrent

1. Introduction
After more than three decades since the first identification of the
Human Immunodeficiency Virus type 1 (HIV-1), the development of
safe and effective preventive vaccines, antiretroviral treatments (ART),
and cure strategies remain major public health priorities [1]. The study
of viral sequences has been central to these efforts, spanning through
different stages of product development. Molecular epidemiology

analyses are widely employed to model viral evolution [2], inform
immunogen selection and design [3], and monitor the circulation of
ART resistance mutations [4]. In vaccine efficacy trials, the exploration
of immune pressure signatures imprinted in viral genomes from
breakthrough cases can help elucidate the mechanism of action [5].
Like other RNA viruses, HIV-1 populations are genetically diverse
and behave as quasispecies (i.e., swarms of highly related but distinct
viral sequences [6]), due to the high rates of viral replication, mutation,
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and recombination [7]. The plasticity of HIV-1 quasispecies allows
them to infect different cell targets [8], escape host immunity [9], and
resist inhibition by ART [10]. A major challenge for the study of this
high level of genetic diversity is the limited capacity of bulk PCR/sequencing techniques to capture the complexity of the viral quasispecies
[11].
The application of single genome amplification (SGA) of subgenomic (i.e., 1.5–3 Kb) [12,13] and full-length genome HIV-1 (i.e., 9
Kb) [14,15] has been a major advancement in the field. This technique
is based on serial dilution of a viral genome template (usually complementary DNA (cDNA) obtained from viral RNA (vRNA) by reverse
transcription) followed by nested PCR of multiple (> 10) replicates.
Based on the Poisson distribution, the dilution that yields ≤30% positive reactions has an 80% probability of deriving from a single amplifiable template [12,13]. This approach allows for the study of multiple viral sequences per patient, preserving linkage among
polymorphisms in the same viral genome copy, with limited impact
from PCR-induced misincorporation/recombination or bacterial selection during cloning [14]. HIV-1 SGA amplicon derived sequences
published to date have been obtained exclusively by capillary sequencing based on the Sanger method (the single exception is the PacBiobased sequencing of pooled single genome amplicons by Dilernia et al.
[16] The Sanger sequencing technique provides reads of length ˜800
base pairs (bp) with low sequencing error, which allows for the
straightforward generation of contigs de novo (i.e., without the need of
a pre-existing reference sequence). This method is based on primerdirected sequencing [17], thus requiring prior knowledge of the target
sequence. In the case of HIV-1, where inter-strain nucleotide sequence
diversity can reach 20% [18], some sequencing reactions may fail due
to mismatches between target and primer, and require the selection of a
second set of sequencing primers to “fill in” the low-coverage areas in
the contig. To achieve the desired level of bidirectional coverage
(usually 4×), ∼6 μg of PCR amplicon is used as substrate for the
multiple dye-termination sequencing reactions.
Recent years have seen an increase in demand for HIV-1 sequencing
in large cohort studies [19–32]. For instance, the sieve analysis of the
RV144 vaccine efficacy trial generated > 1000 HIV-1 env gene SGA
amplicon sequences from 121 patients [33]. Consequently, interest is
increasing in the field for reliable, cost-effective, and scalable alternatives to capillary Sanger sequencing. Here we describe the development, validation, and field-testing of an alternative HIV-1 SGA amplicon sequencing platform based on next-generation sequencing
(NGS).
Unlike capillary sequencing, which allows for a maximum of 96
parallel reactions, NGS allows for millions of parallel reactions [34].
While the high cost of first-generation NGS instruments limited their
availability to sequencing core facilities, by the early 2010′s Life
Technologies and Illumina launched more affordable benchtop NGS
sequencers (i.e., Ion Torrent PGM [35] and MiSeq [36], respectively)
which has allowed for the wider spread of NGS technologies in research
laboratories [37]. Sequence reads obtained by benchtop NGS instruments are of shorter length and lower quality [38] than capillary sequences, thus requiring a large reading redundancy to mitigate sequencing errors [39].
Here we propose a strategy that is based on benchtop NGS, including an accompanying bioinformatics pipeline that can run on
conventional desktops/laptops. Overall, our results demonstrate that
this NGS strategy performs with comparable accuracy to capillary sequencing. Properly incorporated, the NGS platform can accommodate
the increasing needs of HIV-1 SGA amplicon sequencing with its advantages in cost, scalability and ease of data analysis.

Table 1
Sample set used in the validation and field test of HIV-1 env SGA NGS.
Patient

A
B
C
D
E
F
G
H
I
J

Plasma viral load

SGA amplicons (n)

(copies/ml)

log10

44,668
169,824
194,984
5,884
100,000
85,114
11,749
47,863
10,471
154,882

4.65
5.23
5.29
3.77
5.00
4.93
4.07
4.68
4.02
5.19

Validation

Field test

10

11
9
12
9
11
13
13
9
8
6

2. Material and methods
2.1. Population under study
As a part of proactive public health management, we undertook a
characterization of the contemporary HIV epidemic in the US Navy and
Marine Corps [40]. Health system and occupational data as well as
reposed sera from all Sailors and Marines identified as HIV-infected
over a five-year period ending in 2010 were included (n = 496 service
members). In addition to exploring holistic relationships which might
inform public health engagement to reduce service member HIV infection risk, a cluster analysis was performed through molecular
methods [41]. Also, a sub-group of the cohort volunteered and participated in a risk survey [42]. For the current work, samples from 10
random participants were used, meeting the following criteria: 1)
plasma viral load > 5000 copies/ml, and 2) available sample volume > 2.0 ml (which would allow future work on leftover specimens)
(Table 1).
2.2. Single genome amplification of HIV-1 env
vRNA was extracted from plasma samples using the QIAamp Viral
RNA Mini Kit (QIAGEN, Valencia, CA). Single genome amplicons of full
length HIV-1 env were retrieved from vRNA using reverse transcription
(RT) followed by nested PCR as previously described [41]. Briefly, after
RT, cDNA was titrated through nested-PCR of HIV-1 env of 10 replicates/dilution. The dilution that provided 3/10 positive reactions
was used to generate HIV-1 env single genome amplicons [12,13].
2.3. Library preparation and next-generation sequencing
For each single genome amplicon, 100 ng of second round PCR
product was enzymatically sheared to 400 bp followed by barcoding
using the Ion Xpress Plus Fragment Library & Ion Xpress Barcode
Adapters
kits
(LifeTechnologies,
ThermoFisher
Scientific).
Quantification was performed using a 2100 Bioanalyzer (DNA 1000 kit,
Agilent Technologies, Sunnyvale, CA). DNA size-selection was performed using Blue Pippin 2% dye free cassette with internal standard
marker V1 (Sage Science). The size-selected product was equalized
using the Ion Equalizer kit (LifeTechnologies, ThermoFisher Scientific)
following manufacturer’s instructions. All purifications used Agencourt
AMPure XP Reagent (Beckman Coulter).
Emulsion PCR (ePCR) and enrichment for 400 bp sheared product
used the Ion OneTouch 400 bp Template kit (LifeTechnologies,
Carlsbad, CA) on the OneTouch and ES instruments. Sequencing was
carried out using the Ion PGM 400 kit and Ion 316 chip v2 on the
IonTorrent PGM platform (LifeTechnologies, Carlsbad, CA), following
manufacturer’s instructions. For scalability experiments, the ePCR/enrichment of libraries derived from 43 different amplicons were carried
out on the Ion Chef instrument with Ion PGM Hi-Q Chef kit
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Fig. 1. Next-generation sequencing of HIV-1 single genome amplicons. cDNA of HIV-1 env is titrated using serial dilution followed by nested PCR. The dilution that
yields ≤30% of positive reactions is used for downstream library preparation. Amplicons are subject to enzymatic fragmentation, which is visualized on a
Bioanalyzer. Gel electrophoresis is used for size selection (˜400 bp), and ligation of barcodes and sequencing adapters allows for multiplexing dozens of samples in a
single emulsion PCR (ePCR) run. Libraries are then loaded on a 316 chip v2, and Ion sequencing is performed on a PGM instrument. The histogram shows the NGS
read length distribution of a typical run. See text for details.

(LifeTechnologies, Carlsbad, CA) and were sequenced on Ion 318 chips
v2 BC.

determination of consensus sequence Finally, newly-developed ViKiNGS was employed for manual quality control and editing of the final
consensus sequence. The description of these modules is presented in
detail in the Results section, along with examples of their implementation. The software is accessible to interested users through the
execution of individual software licenses with Henry M. Jackson
Foundation for the Advancement of Military Medicine, Inc. Please
contact the corresponding authors.

2.4. Sanger sequencing
To validate the NGS-based platform, Sanger sequencing of HIV-1 env
single genome amplicons was performed as previously described [41].
Contigs of Sanger reads were assembled with Sequencher 5.0 (Gene
Codes Corporation, Ann Arbor, MI).

2.5.2. Reference-guided alignment
Filtered reads were aligned to reference using the Burrows-Wheeler
Aligner (BWA) [45] implemented in tmap version 3.2.2 (by Nils Homer,
distributed through https://github.com/iontorrent/TMAP) using the
following parameters: command = map2; match score = 1; mismatch
penalty = 3; gap open penalty = 5; gap extension penalty = 2; and
soft-clip only the right portion of the read.

2.5. Data analysis
2.5.1. Quality control
FastQ files [43] were exported from the PGM using Torrent Suite 4.4
software (LifeTechnologies, ThermoFisher Scientific). Sequence quality
control was performed using FastQC (courtesy of Dr. Simon Andrews,
Babraham Institute, Cambridge, UK; URL: https://www.bioinformatics.
babraham.ac.uk/projects/fastqc/). FastQ files [43] were then imported
into CLC Genomics Workbench version 7.0.3 (Aarhus, Denmark) to
remove sequencing adapters and trim sequences based on quality
(limit = 0.05; maximal 2 ambiguous nucleotides) and length (minimum
length = 200 nucleotides), followed by barcode-based demultiplexing.
We developed a pipeline, combining published and novel tools, to
obtain the consensus sequence of single genome amplicons sequenced
by NGS. The pipeline is composed of three modules. First, newly-developed tango was used to select a reference sequence to serve as seed
for the initial reference-guided alignment. Then, previously-published
Nautilus [44] and newly-developed SaGA were used for iterative

2.6. Statistical testing
Sequence alignments were generated using HIVAlign [46], and were
manually edited using Geneious 3 (http://www.geneious.com) [47].
The HIV-1 subtype was determined using NCBI Genotyping tool
(https://www.ncbi.nlm.nih.gov/projects/genotyping/formpage.cgi)
and jumping profile Hidden Markov Model (jpHMM) tool [48] (http://
jphmm.gobics.de).
The inter-variant sequence diversity within a sample was visualized
using Highlighter tool [13]. Phylogenetic analyses were conducted
using MEGA6.06 [49] (www.megasoftware.net). Prism version 6.0e
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(GraphPad Software) and JMP10 (SAS Institute, Cary, NC) were used
for summary statistical analyses.
3. Results and discussion
3.1. Model selection
Since its first description, the SGA method has been applied to the
study of the three structural HIV-1 genes (i.e., gag [1.5 kilobases (Kb)],
pol [3 Kb], and env [2.6 Kb]) [12,13,50], as well as half-length (˜5 Kb)
[51] and near full-length genomes (˜9 Kb) [14,51]. HIV-1 env has been a
major focus of SGA amplicon sequencing efforts, due to the importance
of the encoded glycoprotein (Gp160) in viral tropism and antibodymediated immune responses [5,13]. Among HIV-1 structural genes, env
presents the highest level of genetic diversity, with nucleotide sequences differing by up to 20% [http://www.hiv.lanl.gov/]. Moreover,
env presents marked length polymorphism both intra- and inter-patient
[52]. Thus, in the current paper we have focused on the NGS of env SGA
amplicons, as a “worst-case scenario” for difficulty of sequence alignment, and the current platform can be applied to other subgenomic
regions or full-length HIV-1.
3.2. Summary of SGA amplicon library preparation
The preparation of HIV-1 env SGA amplicon NGS libraries is described in detail in the Materials and Methods section (Fig. 1). Briefly,
HIV-1 env SGA amplicons were sheared to 400 bp and were subjected to
adapter/barcode ligation. After emulsion PCR, the libraries were sequenced in IonTorrent PGM 316 chip v2. Reads were exported from the
instrument using the Torrent Server. After filtering low-quality and
short reads (< 200 bp), sequences were exported in FastQ files for
alignment.

Fig. 2. Algorithm for deriving a consensus sequence from HIV-1 single genome
amplicon Using the tango software, the closest published HIV-1 sequence that
can serve as a reference is obtained by applying BLAST on a random sample of
NGS reads (Reference#01). The complete set of NGS reads is then aligned to
Reference#01 using an implementation of BWA [45]. Afterwards, the consensus of the alignment (Reference#02) is derived by analyzing the frequency
of nucleotide bases, insertions, and deletions in the sam file using Nautilus and
SaGA software. Reference#02 is used to guide the alignment of NGS reads and
consensus derivation, in a new iteration, until the “final consensus sequence” is
obtained. See text for details.

3.3. Alignment
In order to allow for the current bioinformatics pipeline to run on a
computer with capabilities usually found in research laboratories, we
selected reference-guided alignment over de novo alignment. The
challenge with the former method is that it requires a reference sequence to which align the reads. In the absence of an autologous (i.e.,
from the same patient) reference, we developed tango, an algorithm
that uses a random sample of the NGS reads to select the closest sequence (“Reference#01” in Fig. 2), using BLAST [53], from a local
database of published HIV-1 sequences, following the model proposed
by Archer et al. [54]. All of the NGS reads were then aligned to Reference#01 using a BWA-based algorithm [45], resulting in a sam file:
“Alignment#01”. Due to HIV-1 vast genetic diversity, Reference#01
will unavoidably represent an “imperfect” reference, which can differ
from the query reads in substitutions, deletions and insertions. We used
Nautilus [44] to explore Alignment#01, tallying the frequency of each
nucleotide base at each position of the alignment (Fig. 3a), and we used
SaGA to derive a consensus sequence depicting the base present at ≥
50% in each position (in the case where no base was present at ≥ 50%,
the position was represented by an “N”). In the cases where the query
reads predominantly presented a deletion, the position was represented
in the consensus by a gap (i.e., “-”). The Concise Idiosyncratic Gapped
Alignment Report (CIGAR) field in the sam file [55] encodes for insertions in the query compared to the reference (the example in Fig. 3b
shows the presence of three insertions in the query reads at 80%: one
trinucleotide and two hexanucleotides). When insertions at a given
position were present in ≥ 50% of the reads, the most frequent motif
was inserted into the consensus (Fig. 3c). The consensus sequence thus
generated, which reconciled differences between Reference#01 and the
query reads, was made into a new reference sequence (Reference#02)
that guided the alignment of NGS reads in a new iteration (Fig. 2). This
process was then repeated, until it resulted in no further improvement;

the obtained sequence was the “final sequence”.
In some instances, SGA amplicon sequences can present ≥1 mixed
bases, due to the presence of > 1 template in the original PCR reaction
[14]. Also, Salazar-Gonzalez et al. have reported on the presence of
mixed bases due to misincorporation by Taq polymerase during initial
PCR cycles [14], emphasizing the importance of using high-fidelity
polymerases. In capillary sequencing, mixed bases are evidence as
overlapping peaks in the chromatogram, but it is not possible to reliably
estimate the frequency of the different variants. Using the current NGS
platform, it is possible to quantify the number of forward and reverse
reads supporting each variant (Fig. 4). This information is particularly
useful when ruling out miscalls due to strand bias. We have designed a
GUI, ViKiNGS, to support the quality control and manual editing of the
“final sequences” (Suppl Fig. 1).
3.4. Validation
In order to assess the accuracy of the NGS platform, we used SGA
amplicons that had been sequenced with capillary Sanger sequencing.
The validation set represented 10 HIV-1 env SGA amplicons from the
same individual (participant "J”) with median inter-variant genetic
distance of 0.86% (range: 0.35–1.13%), distinguishable by substitutions
and insertions/deletions. In 10/10 cases, the NGS results fully match
the capillary Sanger sequences (Fig. 5).
3.5. Field test
The applicability of the NGS platform was assessed on a field test of
additional 101 HIV-1 env SGA amplicons from 10 individuals with
plasma viral loads ranging 5,884-194,984 copies/ml (Table 1). This
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Fig. 3. Example of derivation of single genome amplicon NGS consensus. A) At each alignment position (columns), the sequence of the reference (top) is compared
with the frequency of nucleotide bases or gaps (rows) tallied based on the analysis of the sam file (to ease visualization, frequencies are here presented as a heat map).
Whenever the most frequent base/gap differs from the reference (red border), the sequence of the consensus is modified accordingly (black boxes). B) By analyzing
the CIGAR field in the sam alignment file it is possible to tally the sequences from the NGS reads encoded as “I”, which correspond to “insertion to the reference” (i.e.,
bases present in the NGS reads that do not have a corresponding position in the reference). The plot depicts, at position of the alignment (x-axis), the frequency of the
insertions (y-axis). Data points are color-coded based on the length of the insertion. The arrows depict the sequences of three predominant insertions. Insertions above
the operational threshold (dotted line at 50%) are followed up in downstream analysis, where C) the most common motif (in this case “TAA”) is inserted back into the
new consensus sequence in the corresponding position.
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Fig. 4. NGS-based analysis of mixed bases. A) In amplicon #04 from participant “J” 5/5 Sanger capillary sequencing chromatograms covering position 2516 (red
border) show overlapping peaks for A and G, which would result in an “R” base calling based on the IUPAC nomenclature. The presence of “A” and “G” are also
supported in the NGS reads (heat map on the bottom). B) NGS data shows ˜80% of reads supporting the A and 20% supporting the G, with no directional bias.
Quantitation of NGS reads allows to discriminate between events that should be base called as single vs. mixed bases, in a more consistent manner.

sample set included 6 additional SGA amplicons from the same individual used in the assay validation (participant “J”). All of the sequences were subtype B (Suppl Fig. 2) and the phylogenetic analysis
supported the grouping of sequences from each individual in separate
and distinct clusters (Fig. 6a). The observed profiles included individuals with highly homogeneous viral quasispecies (e.g., participant
“B”), individuals with two highly homogeneous viral lineages (e.g.,
participant “C”), and individuals with heterogeneous viral populations

(e.g., participant “G”) (Fig. 6b and c). Of note, 9/9 SGA amplicons from
participant “H” presented the same premature stop codon in gp160
(codon 24). The capillary Sanger sequencing of the SGA amplicon
showed an open reading frame, while the frame shift observed in NGS
was due to a single-base deletion at codon 9. A detailed inspection of
the NGS data showed that only a minority of the reads (13%) presented
the open reading frame sequence (Suppl Fig. 3). The reason for the
aberrant NGS sequence is unknown, but the presence of an unusually
Fig. 5. Validation of NGS of HIV-1 single genome
amplicons. Ten env amplicons from participant “J”
were subject to Sanger capillary sequencing and NGS.
To ease visualization, the highlighter plot is shown,
where each sequence was compared to the consensus
of the participant, and differences from the consensus
are denoted with color-coded tic marks using the LANL
Highlighter convention (i.e., green = A, blue = C,
orange = G, red = T, and gray = deletion) [13]. Each
cognate pair shows identical patterns indicating 100%
concordance between the two techniques.



G.H. Kijak, et al.

%LRPROHFXODU'HWHFWLRQDQG4XDQWLILFDWLRQ  

Fig. 6. Field test of NGS of HIV-1 single genome amplicons. 101 env amplicons from 10 HIV-1 infected individuals were subject to NGS sequencing. A) the
phylogenetic tree shows separate clustering of sequences from each individual, supported by 100% bootstrap values. The 10 sequences from participant “J” that had
been used in the assay validation are shown in grey. HIV-1 reference sequence HXB2 is depicted. B) Highlighter plot of sequences from each participant show
different within-individual diversity profiles, ranging from highly homogeneous (e.g., participant “B”) to more diverse (e.g., participant “D”). Color-coding is as in
Fig. 5. The 10 sequences from participant “J” that had been used in the assay validation are depicted by the grey bar. C) Pair-wise sequence diversity within each
participant.
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Fig. 7. Scale up of NGS of HIV-1 single genome amplicons. 43 different env amplicons used in the assay validation were multiplexed using distinct barcodes were run
together on a 318 chip v2 BC. The top panel shows the loading efficiency and run metrics. The bottom-left graph shows the per-base coverage for each sequence,
represented by a different line color and the bottom-right graph summarizes the statistics of the 43 sequences. The dotted line indicates 50x coverage.

high GC-content in the vicinity of the affected region (GC = 75%,
compared to genome-wide average GC = 43%) might have affected
NGS reading.

platform has a much lower template requirement (˜100 ng), which
represents a substantial reduction in the cost of library preparation.
2) No need of HIV-1 sequencing primers: HIV-1 sequence diversity is a
major challenge for Sanger-based sequencing. Mismatching between
primers and target sequences usually results in gaps in the contigs,
which require the selection of new sets of primers by a trained operator and the running of additional sequencing reactions to provide
complete coverage. In contrast, the NGS-based platform does not
depend on HIV-1 primers for sequencing; however, it does necessitate an HIV-1 sequence for reference-guided alignment. In the current bioinformatics pipeline, the query for a suitable reference capitalizes from the vast public sequence database (to date 53,666
HIV-1 env sequences have been deposited in the Los Alamos
National Laboratory HIV database, URL:http://www.hiv.lanl.gov/,
accessed 03JAN18).
3) Higher throughput: The large sequencing landscape within a chip
combined with the capacity to multiplex samples using distinguishable barcodes lends the NGS platform the capacity to process
dozens of different samples per run [56]. The throughput of this
platform can be further increased by leveraging automation systems
for library preparation and more efficient bioinformatics pipelines
for sequence handling.
4) Platform independence: While the data presented in the current
study were obtained using the IonTorrent platform, similar analyses
could be perform on other benchtop NGS platforms (i.e., Illumina’s
MiSeq). Moreover, the bioinformatics pipeline is implemented in
Java, which allows for implementation on Windows, Linux, and Mac
OS.

3.6. Scalability
Next, we assessed the capacity of the NGS platform to scale up, in
order to accommodate the increasing demand for SGA amplicon sequencing. The assay validation and field test had been run on
IonTorrent 316 chip v2, and in the following experiment we tested the
318 chip v2 BC, which provides ˜1.8× sequencing capacity compared
to the 316v2 chip. Also, to assist with ePCR/enrichment and chip
loading, we employed the Ion Chef automated system. We ran 43 different HIV-1 env SGA amplicons, which had already been sequenced
during the assay validation and field test. The run resulted in 5.9 million reads, of which 3.9 million (66.1%) had a length > 300 bp. The
number of reads per barcode ranged 704-187,350 (median: 108,548
reads per barcode; inter-quartile range: 26,132-127,354.5). When the
NGS reads were ran through the genotyping pipeline, 41/43 (95%) of
the SGA amplicons presented consistent gene-wide coverage > 50×
(the operational cut-off depth following guidelines by Pelak et al. [56]),
with 37/43 (86%) of the SGA amplicons having a median coverage >
500× (Fig. 7). Consensus sequences matched those obtained in the
previous experiment using 316 chip v2.
3.7. Overall comparison of NGS- and Sanger-based SGA amplicon
sequencing platforms
Motivated by the increase in the demand for HIV-1 SGA amplicon
sequencing, we have developed an NGS-based SGA amplicon sequencing platform. Among the advantages of the NGS-based system are:

The per-base cost of NGS has been rapidly decreasing (Data from the
NHGRI Genome Sequencing Program. URL: https://www.genome.gov/
27541954/dna-sequencing-costs-data/ accessed on 11JAN19), making
the current platform an affordable alternative to Sanger capillary sequencing.
Despite the abovementioned advantages of the NGS-based platform,
it is important to consider that Sanger capillary sequencing is a mature

1) Lower DNA input: the gold standard Sanger sequencing platform
requires ∼6 μg of 2nd round PCR product to support bidirectional
sequencing of HIV-1 env (at 4x coverage), which is usually achieved
by running multiple PCRs in parallel. In contrast, the NGS-based
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technology, widely employed for more than 2 decades, which can
substantially ease assay development and troubleshooting. As shown in
the current field test, NGS-based systems can also be affected by artifacts. Moreover, the use of short-read NGS limits the capacity to assess
the linkage/phasing of polymorphisms, which could be needed to distinguish if the presence of multiple instances of mixed bases in the same
sequence are due to multiple templates in the PCR or misincorporation
by Taq polymerase. As the new technology expands, it will be important
to remain vigilant to systematic errors and the search for technical ways
to mitigate them.
Finally, a third generation of sequencing technologies has been
developed, characterized by longer reads (> 10 Kb) of single molecules
(e.g., SMRT by Pacific Biosciences and MinION by Oxford Nanopore
Technologies). Reports published thus far show promising results regarding the sequencing of complex HIV-1 quasi-species [16,57–59].

[3]
[4]

[5]

[6]
[7]

4. Conclusion

[8]

In the current study, we have demonstrated the applicability of
benchtop NGS platforms for the sequencing of HIV-1 single genome
amplicons. With lower sample requirements and higher throughput,
this approach is suitable to support the increasing demand for highquality HIV-1 sequences in fields such as molecular epidemiology, and
development of preventive and therapeutic strategies.
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